May 6, 2021Nancy Vosnidou appointed by BioConsortia as IP and portfolio strategist
As Davis, California-based BioConsortia continues its discovery and development of powerful microbes with unique modes of action and innovates further into gene editing for microbial biopesticides and nitrogen fixation, the company has announced that Nancy Vosnidou will join the BioConsortia team in the newly created position of IP and portfolio strategist.
Vosnidou brings deep experience in patent portfolio development and strategy, as well as competitive intelligence. Most recently, Vosnidou managed the CRISPR and molecular engineering IP portfolios for Corteva, a multinational ag tech company, with previous IP experience in pharmaceutical biologicals, ag microbials at a unicorn startup, and transgenic crop development with another of the big 5 agricultural companies. Vosnidou holds a Ph.D. in Biophysics, MS in Pathology/Clinical Chemistry, and BS in Biology from University of Missouri.
“We are excited to have someone with this depth of experience, knowledge and skill join our team”, Christina Huben, senior vice president operations and administration., said in a news release. “Creating and protecting our IP is a key part of BioConsortia’s value proposition as a startup”.
BioConsortia recently announced a deal to develop and commercialize nitrogen fixing microbes for non-legume crops with Mosaic, the $9 billion revenue fertilizer company, and has moved into ground-breaking areas of research for natural and gene edited microbial products that are superior in efficacy, high in consistency, beneficial for farming and friendly toward the environment, its natural resources and habitats.
“These are exciting times at BioConsortia. We have built a world-class team, which is doing great research, and we continue to move from strength to strength. Nancy is a very talented addition to this winning team,”said Marcus Meadows-Smith, CEO, BioConsortia Inc..
BioConsortia Inc. is developing effective microbial solutions that enhance plant phenotypes and increase crop yields. The company is pioneering the use of directed selection in identifying teams of microbes – working like plant breeders and selecting plants based on targeted characteristics, then isolating the associated microbial community. Its Advanced Microbial Selection (AMS) process enriches the crop microbiome, allowing researchers to identify organisms that influence the expression of beneficial traits in plants.
BioConsortia Inc. uses a toolkit including multi-trait screening, colonization technologies, microbiome analysis, genomics and gene editing. As a result, the company has a hit rate of high quality leads, some with novel patent-pending metabolites, and an extraordinarily deep pipeline of products in development.
BioConsortia focused on launching products with superior efficacy, higher consistency, and breakthrough technologies in 3 key areas:
1) Biopesticides: a pipeline of biofungicides and nematicides with superior efficacy
2) Biostimulants: growth promoting products that further increase yields in standard, high-yielding, as well as stressed, agronomic conditions
3) Nitrogen-fixation and fertilizer use efficiency: developing products for major non-legume row crops (such as corn and wheat)
Our products are foliar, drench, seed treatment, in-furrow and granule products for a wide range of crops.
For inquiries and further information, contact [email protected].